Pfizer To Provide Individual Participant Data At Scale

By Aida Habtezion, MD, MSC, FRCPC, AGAF

The decision to join a clinical trial is personal. Each and every participant plays an important role in medical advancement. Historically, clinical trial sponsors have used participants’ data to learn more about the safety and efficacy of new treatments. But now, participants can have consistent and reliable access to their individual data. Pfizer has made a commitment to return individuals’ data to its clinical trial participants through its Participant Data Return initiative.